World
Glaxo to Make 1 Billion Doses of Pandemic Vaccine Booster
- Drugmaker started manufacturing after reviewing network
- Plan follows Glaxo’s collaboration with Sanofi last month
Source: GlaxoSmithKline Plc
This article is for subscribers only.
Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.
GlaxoSmithKline Plc plans to produce 1 billion doses of a vaccine adjuvant -- a booster that can help any brand of shot -- to support immunization against the Covid-19 pandemic next year.